Simone Song is the founder of ORI Capital, and the senior partner of ORI Healthcare Funds which focuses on investing in early-stage and innovative healthcare companies globally.
Simone is the architect of ORIzon, a big data-driven AI research platform which enables ORI Capital to become a quantitative venture capital fund manager that combines quantitative analysis with fundamental research.
Simone serves on the boards of directors of various investee companies of ORI Healthcare Funds, including being the chairman of AffyImmune and being the directors of CG Oncology, Enable Injections, Pillar Biosciences and TriSalus.
Simone was the former Head of Goldman Sachs Healthcare Investment Banking for Greater China. Prior to joining Goldman Sachs, she was a Managing Director of Cowen Group, a member of the advisory board of AXA Investment Managers and an executive board advisor to AXA Asia Pacific Holdings.
Simone received a BA in Economics from Fudan University in China and a MA in Economics from Claremont Graduate School.
TriSalus assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site’s endorsement of TriSalus or this website.
Thank you for visiting our site.